Merck (BSP:MRCK34) Accumulated other comprehensive income (loss) : R$-25,288 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Merck Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Merck's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was R$-25,288 Mil.

Merck's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2023 (R$-23,783 Mil) to Sep. 2023 (R$-24,279 Mil) and declined from Sep. 2023 (R$-24,279 Mil) to Dec. 2023 (R$-25,288 Mil).

Merck's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 (R$-25,046 Mil) to Dec. 2022 (R$-25,010 Mil) but then declined from Dec. 2022 (R$-25,010 Mil) to Dec. 2023 (R$-25,288 Mil).

Merck Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Merck's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Accumulated other comprehensive income (loss) Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-25,419.17

-34,129.94

-25,045.55

-25,010.07

-25,287.87

Merck Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-25,433.59	-23,783.13	-24,278.65	-25,287.87	-

Merck Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Merck Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Merck's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (BSP:MRCK34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BSP:MRCK34) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (BSP:MRCK34) Headlines

No Headlines